| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |